Demographics (3)
- AGE - Subject age at enrollment (phv00559007.v1.p1)
- SEX - Biological sex (phv00559006.v1.p1)
- SEX - Biological sex (phv00559002.v1.p1)
Disease Events (1)
- HIV - HIV serostatus (baseline) (phv00559008.v1.p1)
Other (26)
- ABNORMAL_XRAY - Chest x-ray indicated effusion and/or infiltrate, whether unilateral or bilateral, close to baseline. (phv00559017.v1.p1)
- ANALYTE_TYPE - Analyte of sample (phv00559029.v1.p1)
- ANYEDEMA - Edema at any body site, baseline physical exam (phv00559015.v1.p1)
- BEST_RESP - Participant best response to systemic chemotherapy (phv00559024.v1.p1)
- CD4COUNT - CD4 count at baseline (phv00559021.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00559001.v1.p1)
- DIED - Vital status at study exit (phv00559022.v1.p1)
- FIRSTKSMO - Months since first KS lesion noticed by participant, self-reported at baseline (phv00559009.v1.p1)
- FUDY - Number of follow up days for participant, from visit 1 (baseline) to exit (first of: death; lost to follow up; other exit reason; or study completion). (phv00559023.v1.p1)
- HIVRNA - HIV viral load at baseline (phv00559020.v1.p1)
- I_STAGE - AIDS Clinical Trials Group (ACTG) stage I(mmune), based on baseline CD4 count (phv00559012.v1.p1)
- IS_TUMOR - Tumor status (phv00559028.v1.p1)
- KARNOFSKY - Karnofsky performance at baseline, physical exam by clinician (phv00559016.v1.p1)
- KSHV - Indicator of whether KSHV was detected by PCR in plasma sample at baseline (phv00559018.v1.p1)
- KSHV_TITER - KSHV plasma titer at baseline (phv00559019.v1.p1)
- LESIONBIOLOC - Location of biopsied lesion (phv00559026.v1.p1)
- LESIONBIOTYPE - Biopsied lesion morphology (phv00559027.v1.p1)
- LESIONSITES - Number of body sites with one or more KS lesions at baseline of the 8 sites: Head/neck; oral hard palate; oral non-hard palate; arms/hands; chest/abdomen; groin/genitals; back; legs/feet (phv00559013.v1.p1)
- S_STAGE - AIDS Clinical Trials Group (ACTG) stage S(ymptoms), largely based on self-report of previous opportunistic infections and B-symptoms (phv00559011.v1.p1)
- SAMPLE_ID - Sample ID (phv00559025.v1.p1)
- SAMPLE_ID - Sample ID (phv00559004.v1.p1)
- SUBJECT_ID - Subject ID (phv00559005.v1.p1)
- SUBJECT_ID - Subject ID (phv00559000.v1.p1)
- SUBJECT_ID - Subject ID (phv00559003.v1.p1)
- T_STAGE - AIDS Clinical Trials Group (ACTG) Stage T(umor), based on physical exam results (phv00559010.v1.p1)
- TOTLESIONSNUM - Total count of lesions on body at physical exam (baseline) (phv00559014.v1.p1)